基于网络药理学和分子对接探讨槐花抗2型糖尿病作用机制研究
Study on Anti-Type 2 Diabetes Mechanism of Sophora japonica L. based on Network Pharmacology and Molecular Docking
DOI: 10.12677/PI.2021.104025, PDF,  被引量    科研立项经费支持
作者: 方镕泽, 蒙燕瑶：贵州中医药大学，贵州 贵阳；唐秀胜：遵义市中医药院，贵州 遵义；李小芬：成都中医药大学，四川 成都；王祥培*：贵州民族大学，贵州 贵阳
关键词: 槐花；2型糖尿病；作用机制；网络药理学；分子对接；Sophora Japonica L.； Type 2 Diabetes； Mechanism of Action； Network Pharmacology； Molecular Docking
摘要: 目的：槐花具有抗2型糖尿病的潜力，但其作用机制尚不明确。方法：通过TCMSP检索筛选槐花的活性成分及靶点，在GeneCards数据库中寻找2型糖尿病的相关靶点，取交集基因进行蛋白互作分析发现，GO生物富集及Kegg富集分析，最后采用分子对接进行验证。结果：得到槐花的活性成分有6个，取交集基因得到93个，蛋白互作分析发现JUN、TP53和MAPK1治疗2型糖尿病的作用，Kegg富集结果发现，槐花治疗2型糖尿病主要通过pathways in cancer、HIF-1 signaling pathway等信号通路进行调控。分子对接结果表明，槐花中的活性成分kaempferol、beta-sitosterol、quercetin等成分与JUN、TP53和MAPK1具有较好的结合能力。结论：槐花可能是通过kaempferol、beta-sitosterol、quercetin等化学成分调控HIF-1 signaling pathway等信号通路上的JUN、TP53和MAPK1等基因发挥治疗2型糖尿病作用。
Abstract: Objective: Sophora japonica L. has the potential of antitype 2 diabetes, but its mechanism is not clear. Methods: Tcmsp was used to search and screen the active components and targets of Sophora japonica L., and the related targets of type 2 diabetes mellitus were found in GeneCards database. Protein interaction analysis was carried out on the cross genes. Go (BP) and KEGG enrichment analyses were carried out. Finally, molecular docking was used to verify the results. Results: There were 6 active components of Sophora japonica L., and 93 of them were obtained by taking the intersection genes. Protein interaction analysis revealed the effect of JUN, TP53 and MAPK1 in the treatment of type 2 diabetes. KEGG enrichment results showed that the treatment of type 2 diabetes by Sophora japonica L. was mainly regulated by Pathways in cancer and HIF-1 signaling pathway. Molecular docking results showed that active components such as kaempferol, beta-sitosterol and quercetin of Sophora japonica L. had the good binding ability with JUN, TP53 and MAPK1. Conclusion: A. sophorae L .may play an important role in the treatment of type 2 diabetes mellitus by regulating the genes of JUN, TP53 and MAPK1 in HIF-1 signaling pathway and other chemical components such as kaempferol, beta-sitosterol and quercetin.
文章引用：方镕泽, 蒙燕瑶, 唐秀胜, 李小芬, 王祥培. 基于网络药理学和分子对接探讨槐花抗2型糖尿病作用机制研究[J]. 药物资讯, 2021, 10(4): 193-202. https://doi.org/10.12677/PI.2021.104025

参考文献

[1] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版) [J]. 中国糖尿病杂志, 2018, 10(1): 64-67.
[2] 毛倩云, 王琛. 慢性炎性反应在糖尿病胰岛β细胞功能损伤中作用的新进展[J]. 上海医学, 2019, 42(4): 242-246.
[3] 国家药典委员会. 中华人民共和国药典[M]. 北京: 中国医药科技出版社, 2015.
[4] 韩玲玲, 樊海瑞, 林明珠, 赵岩. 槐花醇提物对2型糖尿病合并高尿酸血症小鼠疗效研究[J]. 中药材, 2017, 40(11): 2697-2700.
[5] 张伟云, 王丽荣, 许长江, 等. 槐花提取物降血糖活性研究[J]. 上海中医药杂志, 2017, 51(05): 93-97.
[6] 邓桂珠, 林捷欣, 吴纯伟, 等. 复方脑脉通治疗缺血性脑中风多靶点作用的分子对接[J]. 中成药, 2016, 38(8): 1673-1678.
[7] 樊启猛, 杨岩涛, 肖美凤, 等. 基于分子对接技术的补阳还五汤成分与缺血性脑卒中靶点的相互作用研究[J]. 中草药, 2019, 50(17): 4200-4208.
[8] 任艳, 邓燕君, 马焓彬, 等. 网络药理学在中药领域的研究进展及面临的挑战[J]. 中草药, 2020, 51(18): 4789-4797.
[9] 钱文文, 辛宝, 史传道. 槐花的营养保健功能及食品开发前景[J]. 农产品加工, 2016(18): 59-61.
[10] 苗明三, 李彩荣, 陈元朋. 槐花总黄酮对大鼠糖尿病模型血清胰岛素、瘦素和C-肽水平的影响[J]. 中国现代应用药学, 2011(10): 896-898.
[11] 汤利华, 方超, 王浩然, 等. 山奈酚对高糖诱导的糖尿病肾病大鼠肾功能和组织病理损伤的保护作用[J]. 免疫学杂志, 2018, 34(12): 1041-1046.
[12] 李文雯, 钟大鹏, 张卫, 任丽, 程莹. 槲皮素对糖尿病大鼠胰岛β细胞损伤的保护作用及机制研究[J]. 广西医科大学学报, 2021, 38(2): 298-303.
[13] Kung, C.P. and Murphy, M.E. (2016) The role of the p53 tumor sppressor in metabolim and diabetes. Joumal of Endocrinology, 231, R61-R75. [Google Scholar] [CrossRef] 
[14] Shi, Y., Zhang, Y., Wang, C., et al. (2008) Suppressor of cytokine sig-naling-1reduces high glucose-induced TGF-beta1 and fibronectin synthesis in human mesangial cells. FEBS Letters, 582, 3484-3488. [Google Scholar] [CrossRef] [PubMed]
[15] Mao, C.P. and Gu, Z.L. (2005) Puerarin Reduces Increased C-Fos, C-Jun, and Type IV Collagen Expression Caused by High Glucose in Glomerular Mesangial Cells. Acta Phar-macologica Sinica, 26, 982-998. [Google Scholar] [CrossRef] [PubMed]
[16] 周凤娇, 张丽坤, 苏彦君, 张建勇, 安志霞. 青蒿素对糖尿病大鼠肾组织c-jun及c-fos基因表达上调的抑制作用[J]. 现代中西医结合杂志, 2014(21): 2294-2295+2298.
[17] 李媛, 刘明明, 张坚. 缺氧诱导因子1α与糖尿病并发症微循环学研究进展[J]. 中国糖尿病杂志, 2019, 27(10): 793-796.